Table 2.
Lipid profile parameters in normal, diabetic control and diabetic treated groups.
| Parameters | Normal | Diabetic control | Diabetic treated with glimepiride | Diabetic treated with MSCs-CMT | Diabetic treated with MSCs-CMP |
|---|---|---|---|---|---|
| Cholesterol (mg/dL) | 102.67 ± 5.65a | 211.17 ± 5.40d | 178.33 ± 6.23c | 144.33 ± 2.95b | 105.17 ± 3.19a |
| Triglycerides (mg/dL) | 80.83 ± 2.72a | 157.60 ± 3.30d | 113.67 ± 3.45c | 102.67 ± 2.11b | 82.00 ± 2.65a |
| HDL-C (mg/dL) | 54.67 ± 0.88c | 37.33 ± 1.09a | 47.00 ± 0.63b | 52.50 ± 0.99c | 55.00 ± 0.45c |
| LDL-C (mg/dL) | 32.45 ± 1.20a | 134.97 ± 3.25d | 113.33 ± 4.77c | 70.83 ± 3.52b | 36.83 ± 1.14a |
| vLDL-C (mg/dL) | 15.55 ± 0.19a | 31.70 ± 0.96d | 22.67 ± 0.89c | 19.33 ± 0.67b | 16.32 ± 0.78a |
Values are expressed as Mean ± SE of 10 rats in each group. Values, which have different superscript symbols (a, b, c and d) for each parameter, are significantly different at p < 0.05. MSCs-CMT, MSCs-CM injected daily into tail vein; MSCs-CMP, MSCs-CM injected directly in pancreas; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; vLDL-C, very low-density lipoprotein cholesterol.